Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
about
Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localizationA muscle stem cell for every muscle: variability of satellite cell biology among different muscle groupsO-Mannosylation and human diseaseA phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins.Glycoproteomic characterization of recombinant mouse α-dystroglycan.Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycanProtein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypesWhat do mouse models of muscular dystrophy tell us about the DAPC and its components?Glycobiology of α-dystroglycan and muscular dystrophy.Protein O-mannosylation is crucial for human mesencyhmal stem cells fate.Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse.Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.Major glycan structure underlying expression of the Lewis X epitope in the developing brain is O-mannose-linked glycans on phosphacan/RPTPβ.
P2860
Q24634095-6A910A8C-1EBA-4B9B-BDB2-474981EDF583Q26779289-BC91DD4E-5FAE-41C7-9D42-8B9EFB6213F6Q27014986-85556629-5BBD-4327-BC8C-BF5098B6FB5CQ30442278-C822457A-587C-4873-A312-1CD6256635D2Q34126184-F481F360-A7B0-4122-9536-9863A49D63FCQ35841883-75DBB795-8A98-4587-9EA7-C6DB3C6A3111Q37015841-4253B57F-AF0B-44A7-889A-003DDD3065EDQ37200133-8C6336D5-2B91-4F9C-B613-0D41EB759C26Q37723603-F01567F3-C16F-49A2-B192-C24D89F2AC17Q38255744-EE5F22A3-BBB2-4716-B098-8802838E22C7Q38266217-BB82C8C7-C47B-4CBA-A7F0-EC4BF9361E07Q40657565-365C5E15-B6A8-4519-9646-5869E01A0BA0Q42070882-AB16670E-33F8-4939-AF86-0E5D14BE2C50Q48104215-A5A574C4-36C2-439F-B96E-0F4313DEC374Q48469093-C3967F83-9874-4924-A7C4-8EB4D2E1DB6B
P2860
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@en
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@nl
type
label
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@en
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@nl
prefLabel
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@en
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
@nl
P2093
P1476
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro
@en
P2093
Fumiaki Saito
Hironori Kanesaki
Hiroshi Manya
Kaori Miyamoto
Kiichiro Matsumura
Michiko R Wada
Shigeki Yuasa
Shin'ichi Takeda
Tamao Endo
Yuko Miyagoe-Suzuki
P304
P356
10.1016/J.MOD.2008.12.001
P577
2008-12-16T00:00:00Z